BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 18223652)

  • 1. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20.
    Coornaert B; Baens M; Heyninck K; Bekaert T; Haegman M; Staal J; Sun L; Chen ZJ; Marynen P; Beyaert R
    Nat Immunol; 2008 Mar; 9(3):263-71. PubMed ID: 18223652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.
    Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D
    J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proteolytic activity of the paracaspase MALT1 is key in T cell activation.
    Rebeaud F; Hailfinger S; Posevitz-Fejfar A; Tapernoux M; Moser R; Rueda D; Gaide O; Guzzardi M; Iancu EM; Rufer N; Fasel N; Thome M
    Nat Immunol; 2008 Mar; 9(3):272-81. PubMed ID: 18264101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
    Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
    Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage by MALT1 induces cytosolic release of A20.
    Malinverni C; Unterreiner A; Staal J; Demeyer A; Galaup M; Luyten M; Beyaert R; Bornancin F
    Biochem Biophys Res Commun; 2010 Oct; 400(4):543-7. PubMed ID: 20804738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MALT1 auto-proteolysis is essential for NF-κB-dependent gene transcription in activated lymphocytes.
    Baens M; Bonsignore L; Somers R; Vanderheydt C; Weeks SD; Gunnarsson J; Nilsson E; Roth RG; Thome M; Marynen P
    PLoS One; 2014; 9(8):e103774. PubMed ID: 25105596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation.
    Che T; You Y; Wang D; Tanner MJ; Dixit VM; Lin X
    J Biol Chem; 2004 Apr; 279(16):15870-6. PubMed ID: 14754896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative expression pattern of MALT1-A20-NF-κB in patients with rheumatoid arthritis.
    Wang X; Zhu L; Liao Z; Zhang F; Xu L; Xu Y; Chen S; Yang L; Zhou Y; Li Y
    J Immunol Res; 2014; 2014():492872. PubMed ID: 24971370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1.
    Staal J; Driege Y; Bekaert T; Demeyer A; Muyllaert D; Van Damme P; Gevaert K; Beyaert R
    EMBO J; 2011 May; 30(9):1742-52. PubMed ID: 21448133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression.
    Afonina IS; Elton L; Carpentier I; Beyaert R
    FEBS J; 2015 Sep; 282(17):3286-97. PubMed ID: 25996250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-κB signaling.
    Elton L; Carpentier I; Staal J; Driege Y; Haegman M; Beyaert R
    FEBS J; 2016 Feb; 283(3):403-12. PubMed ID: 26573773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The paracaspase MALT1 cleaves the LUBAC subunit HOIL1 during antigen receptor signaling.
    Douanne T; Gavard J; Bidère N
    J Cell Sci; 2016 May; 129(9):1775-80. PubMed ID: 27006117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions.
    Noels H; van Loo G; Hagens S; Broeckx V; Beyaert R; Marynen P; Baens M
    J Biol Chem; 2007 Apr; 282(14):10180-9. PubMed ID: 17287209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling.
    Klein T; Fung SY; Renner F; Blank MA; Dufour A; Kang S; Bolger-Munro M; Scurll JM; Priatel JJ; Schweigler P; Melkko S; Gold MR; Viner RI; Régnier CH; Turvey SE; Overall CM
    Nat Commun; 2015 Nov; 6():8777. PubMed ID: 26525107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.
    Hosokawa Y
    Apoptosis; 2005 Jan; 10(1):25-34. PubMed ID: 15711920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.
    Garrison JB; Samuel T; Reed JC
    Oncogene; 2009 Apr; 28(13):1584-93. PubMed ID: 19234489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation.
    Lee KY; D'Acquisto F; Hayden MS; Shim JH; Ghosh S
    Science; 2005 Apr; 308(5718):114-8. PubMed ID: 15802604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of protein kinase C theta, Bcl10, or Malt1 selectively impairs proliferation and NF-kappa B activation in the CD4+ T cell subset.
    Kingeter LM; Schaefer BC
    J Immunol; 2008 Nov; 181(9):6244-54. PubMed ID: 18941215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells.
    Ho L; Davis RE; Conne B; Chappuis R; Berczy M; Mhawech P; Staudt LM; Schwaller J
    Blood; 2005 Apr; 105(7):2891-9. PubMed ID: 15598810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathways: targeting MALT1 paracaspase activity in lymphoma.
    Fontán L; Melnick A
    Clin Cancer Res; 2013 Dec; 19(24):6662-8. PubMed ID: 24004675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.